Robocath demonstrates safety and efficacy of its R-OneTM medical robotic platform
Discngine receives €600,000 ($743K) from Bpifrance
Metafora biosystems receives reimbursement for test to help diagnose De Vivo disease
Sebia launches new-generation serum free light chain (sFLC) assays for multiple myeloma testing
Noventure and Laboratorios Salvat enter into agreement to commercialise innovative medical device in Spain and Portugal for rhinitis and rhinosinusitis
The Vygon Group welcomes Anne Najaint as CFO
Robocath sets up medical advisory board composed of international interventional cardiology key leaders
